The neuroguide™ electrode introducer kit allows verification of expected Deep Brain Stimulation (DBS) electrode position relative to targeted anatomy using Magnetic Resonance Imaging (MRI).
Lab2Clinic™ CNS drug delivery service is an innovative concept which leverages Renishaw’s extensive experience in neurological drug delivery to accelerate the drug development timeline, aiding translation from research to clinical trials.
projít na článekIntraparenchymal drug delivery offers a practical method of bypassing the blood-brain barrier (BBB) and shows great promise in providing the next step change in the treatment of neurodegenerative, neuro oncology and other debilitating neurological conditi
projít na článekDiffuse intrinsic pontine glioma (DIPG) is a rare but deadly brain tumour. No child has ever survived it, most becoming paralysed and dying in just a few months. Now an novel investigational drug delivery system, which delivers therapeutic agents directly
projít na článekGlobal engineering technologies company, Renishaw, is pleased to announce that its award-winning neuroinfuse™ drug delivery device, the only platform currently to allow for repeated, intermitent infusions into the the parenchyma, has continued to safely a
projít na článekinVia has high overall system efficiency, quality optics, optimised laser delivery and efficient light handling, so you can acquire your Raman data rapidly
projít na článek